FINWIRES · TerminalLIVE
FINWIRES

Market Chatter: Taiwan Stock Market Surpasses India to Become World's Fifth-Largest

By

Taiwan has overtaken India in total stock market value, becoming the world's fifth-largest equity market, Bloomberg News reported Tuesday.

Taiwan's market capitalization reached $4.95 trillion on Monday, slightly ahead of India's $4.92 trillion, according to Bloomberg data. Only the United States, China, Japan and Hong Kong now rank ahead of Taiwan globally.

The gains were driven largely by Taiwan Semiconductor Manufacturing (TPE:2330), whose shares have surged 49% this year amid strong demand tied to the artificial intelligence boom. The chipmaker now accounts for about 42% of Taiwan's benchmark TAIEX index, according to the report.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Related Articles

Asia

Market Chatter: Nvidia to Invest $150 Billion Annually in Taiwan

Nvidia plans to invest around $150 billion annually in Taiwan, calling the island-nation the "epicenter" of the AI revolution, Reuters reported Wednesday, citing Nvidia CEO Jensen Huang.Huang made the comments at a launch event for Nvidia's planned Taiwan headquarters in Taipei. The new headquarters, expected to break ground this year and begin operations by 2030, will employ around 4,000 people, according to the report.Huang also said Taiwan would remain a global technology manufacturing hub for years to come as demand for AI computing continues to grow, the newswire reported.(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

$^TWII
Asia

Hengrui Pharmac Gets China Nod for B-Cell Cancer Drug Trial

Jiangsu Hengrui Pharmaceuticals (SHA:600276) unit Chengdu Sdiya Biopharmaceutical received China's regulatory approval to start clinical trials for HRS-1635 tablets.The approval is for the anti-tumor drug's clinical research in B-cell malignancies, according to a Tuesday filing with the Shanghai bourse.Shares of the pharmaceutical company rose 2% in recent trade.

$SHA:600276
Asia

Shanghai Zhida Technology to Join FTSE Total-Cap Index in June; Shares Gain 3%

Shanghai Zhida Technology Development's (HKG:2650) shares will be added to the FTSE Global Equity Index Series following the latest quarterly review, according to a Tuesday Hong Kong bourse filing.Shares of the EV charging systems maker were up nearly 3% in Wednesday afternoon trade.The company said its shares will be included in the FTSE Global Equity Index Series Micro Cap and FTSE Total-Cap Index.The index changes will take effect after the market closes on June 19.

$HKG:2650